MALAT1 overexpression promotes lipid accumulation, hepatic steatosis, and insulin resistance by increasing the expression of SREBP-1c, a sterol regulatory binding protein that is activated mainly by insulin, and the target genes ACC1, ACLY, SCD1, and FAS [76]. This evidence concerns the gene MALAT1 and fatty liver disease.